Current Pharmaceutical Design
Title: Preface [Hot Topic:Anabolic Agents for the Treatment of Osteoporosis (Executive Editor: Naohisa Miyakoshi)]
Volume: 10 Issue: 21
Author(s): Naohisa Miyakoshi
Affiliation:
Export Options
About this article
Cite this article as:
Miyakoshi Naohisa, Preface [Hot Topic:Anabolic Agents for the Treatment of Osteoporosis (Executive Editor: Naohisa Miyakoshi)], Current Pharmaceutical Design 2004; 10 (21) . https://dx.doi.org/10.2174/1381612043383746
DOI https://dx.doi.org/10.2174/1381612043383746 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
9
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data
Current Drug Safety Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome
Current Pharmacogenomics and Personalized Medicine Current and Emerging Strategies in Osteoporosis Management
Current Pharmaceutical Design The Synthetic Oleanane Triterpenoid HIMOXOL Induces Autophagy in Breast Cancer Cells via ERK1/2 MAPK Pathway and Beclin-1 Up-regulation
Anti-Cancer Agents in Medicinal Chemistry VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
CNS & Neurological Disorders - Drug Targets Risk Factors for Heart Failure Progression and Outcomes
Current Cardiology Reviews Stroke and Hypertension: An Appraisal from Pathophysiology to Clinical Practice
Current Vascular Pharmacology The Role of HTS in Drug Discovery at the University of Michigan
Combinatorial Chemistry & High Throughput Screening Meet Our Editorial Board Member
Current Tissue Engineering (Discontinued) Novel Functions of MicroRNA-17-92 Cluster in the Endocrine System
Current Drug Targets Comparison of the Effects of Dexamethasone Administration on Postoperative Sequelae Before and After “Third Molar" Extraction Surgeries
Endocrine, Metabolic & Immune Disorders - Drug Targets Natural Products Derived from the Mediterranean Diet with Antidiabetic Activity: from Insulin Mimetic Hypoglycemic to Nutriepigenetic Modulator Compounds
Current Pharmaceutical Design Use of Paediatric Xylometazoline Nasal Drop is not a Child’s Play in Hypertensive Patients on Bisoprolol: A Case Report
Current Drug Safety Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Current Pharmaceutical Design Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine
Current Pharmaceutical Design Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Diabetes Reviews Prevalence of Diabetes Ketoacidosis Rises and Still No Strict Treatment Adherence
Current Diabetes Reviews Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry